摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,7b,11,11,13a,13b-hexamethyl-1,2,2a1,6a,7,7a,7b,8,9,10,11,11a,12,13,13a, 13b-hexadecahydronaphtho[20,10:4,5]indeno[7,1-de][1,3]dioxepin-10-ol

中文名称
——
中文别名
——
英文名称
3,7b,11,11,13a,13b-hexamethyl-1,2,2a1,6a,7,7a,7b,8,9,10,11,11a,12,13,13a, 13b-hexadecahydronaphtho[20,10:4,5]indeno[7,1-de][1,3]dioxepin-10-ol
英文别名
(1R,2R,5R,7S,10R,11R,13R,21S)-1,2,6,6,10,17-hexamethyl-14,16-dioxapentacyclo[11.7.1.02,11.05,10.018,21]henicos-17-en-7-ol
3,7b,11,11,13a,13b-hexamethyl-1,2,2a1,6a,7,7a,7b,8,9,10,11,11a,12,13,13a, 13b-hexadecahydronaphtho[20,10:4,5]indeno[7,1-de][1,3]dioxepin-10-ol化学式
CAS
——
化学式
C25H40O3
mdl
——
分子量
388.591
InChiKey
ALFDMOBMDFGAMS-RJLPMABKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.6
  • 重原子数:
    28
  • 可旋转键数:
    0
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.92
  • 拓扑面积:
    38.7
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    3,7b,11,11,13a,13b-hexamethyl-1,2,2a1,6a,7,7a,7b,8,9,10,11,11a,12,13,13a, 13b-hexadecahydronaphtho[20,10:4,5]indeno[7,1-de][1,3]dioxepin-10-ol臭氧 作用下, 以 四氢呋喃二氯甲烷 为溶剂, 以80%的产率得到3-hydroxy-4,4,8,10,14-pentamethyl-17-oxohexadecahydro-1H-cyclopenta[a]phenanthren-12-yloxymethyl acetate
    参考文献:
    名称:
    Synthesis of selective 11 β -HSD1 inhibitors based on dammarane scaffold
    摘要:
    Inspired by natural 11 beta-HSD1 inhibitors hupehenols A - E, a ring-focused strategy was applied for the synthesis of 35 structurally diverse dammarane-type derivatives. These derivatives were effectively prepared from protopanaxadiol based on the modification of rings A and D. Among these compounds, ten were identified as selective 11 beta-HSD1 inhibitors (IC50 range: 101-1047 nM, SI range: 8-169) which exhibited inhibitory activities against human or mouse 11 beta-HSD1. Otherwise, we found 23a could selectively inhibit both human and mouse 11 beta-HSD1 with IC50 value of 994 and 213 nM (SI > 10 and > 47), respectively. Additionally, the molecular modelling results of 23a docking into the human and mouse 11 beta-HSD1 were in good agreement with the results from the enzyme inhibitory experiment. Moreover, valuable structural-activity relationship (SAR) information of dammarane-type 11 beta-HSD1 inhibitor was summarized. (C) 2017 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2017.04.059
  • 作为产物:
    描述:
    碘代三甲硅烷 、 1-[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-3,12-bis(methoxymethoxy)-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone 在 六甲基二硅氮烷四丁基氟化铵 作用下, 以 二氯甲烷四氢呋喃 为溶剂, 反应 16.0h, 以81%的产率得到3,7b,11,11,13a,13b-hexamethyl-1,2,2a1,6a,7,7a,7b,8,9,10,11,11a,12,13,13a, 13b-hexadecahydronaphtho[20,10:4,5]indeno[7,1-de][1,3]dioxepin-10-ol
    参考文献:
    名称:
    Synthesis of selective 11 β -HSD1 inhibitors based on dammarane scaffold
    摘要:
    Inspired by natural 11 beta-HSD1 inhibitors hupehenols A - E, a ring-focused strategy was applied for the synthesis of 35 structurally diverse dammarane-type derivatives. These derivatives were effectively prepared from protopanaxadiol based on the modification of rings A and D. Among these compounds, ten were identified as selective 11 beta-HSD1 inhibitors (IC50 range: 101-1047 nM, SI range: 8-169) which exhibited inhibitory activities against human or mouse 11 beta-HSD1. Otherwise, we found 23a could selectively inhibit both human and mouse 11 beta-HSD1 with IC50 value of 994 and 213 nM (SI > 10 and > 47), respectively. Additionally, the molecular modelling results of 23a docking into the human and mouse 11 beta-HSD1 were in good agreement with the results from the enzyme inhibitory experiment. Moreover, valuable structural-activity relationship (SAR) information of dammarane-type 11 beta-HSD1 inhibitor was summarized. (C) 2017 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2017.04.059
点击查看最新优质反应信息

同类化合物

(5β)-17,20:20,21-双[亚甲基双(氧基)]孕烷-3-酮 (5α)-2′H-雄甾-2-烯并[3,2-c]吡唑-17-酮 (3β,20S)-4,4,20-三甲基-21-[[[三(异丙基)甲硅烷基]氧基]-孕烷-5-烯-3-醇-d6 (25S)-δ7-大发酸 (20R)-孕烯-4-烯-3,17,20-三醇 (11β,17β)-11-[4-({5-[(4,4,5,5,5-五氟戊基)磺酰基]戊基}氧基)苯基]雌二醇-1,3,5(10)-三烯-3,17-二醇 齐墩果酸衍生物1 黄麻属甙 黄芪皂苷III 黄芪皂苷 II 黄芪甲苷 IV 黄芪甲苷 黄肉楠碱 黄果茄甾醇 黄杨醇碱E 黄姜A 黄夹苷B 黄夹苷 黄夹次甙乙 黄夹次甙乙 黄夹次甙丙 黄体酮环20-(乙烯缩醛) 黄体酮杂质EPL 黄体酮杂质1 黄体酮杂质 黄体酮杂质 黄体酮EP杂质M 黄体酮EP杂质G(RRT≈2.53) 黄体酮EP杂质F 黄体酮6-半琥珀酸酯 黄体酮 17alpha-氢过氧化物 黄体酮 11-半琥珀酸酯 黄体酮 麦角甾醇葡萄糖苷 麦角甾醇氢琥珀酸盐 麦角甾烷-6-酮,2,3-环氧-22,23-二羟基-,(2b,3b,5a,22R,23R,24S)-(9CI) 麦角甾烷-3,6,8,15,16-五唑,28-[[2-O-(2,4-二-O-甲基-b-D-吡喃木糖基)-a-L-呋喃阿拉伯糖基]氧代]-,(3b,5a,6a,15b,16b,24x)-(9CI) 麦角甾烷-26-酸,5,6:24,25-二环氧-14,17,22-三羟基-1-羰基-,d-内酯,(5b,6b,14b,17a,22R,24S,25S)-(9CI) 麦角甾-8-烯-3-醇 麦角甾-8,24(28)-二烯-26-酸,7-羟基-4-甲基-3,11-二羰基-,(4a,5a,7b,25S)- 麦角甾-7,22-二烯-3-酮 麦角甾-7,22-二烯-17-醇-3-酮 麦角甾-5,24-二烯-26-酸,3-(b-D-吡喃葡萄糖氧基)-1,22,27-三羟基-,d-内酯,(1a,3b,22R)- 麦角甾-5,22,25-三烯-3-醇 麦角甾-4,6,8(14),22-四烯-3-酮 麦角甾-1,4-二烯-3-酮,7,24-二(乙酰氧基)-17,22-环氧-16,25-二羟基-,(7a,16b,22R)-(9CI) 麦角固醇 麦冬皂苷D 麦冬皂苷D 麦冬皂苷 B